33 Recruiting HIV-1-infection Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for HIV-1-infection
Top Recruiting HIV-1-infection Studies
Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1
📍 Children's National Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
📍 Be Well Medical Center — Berkeley, California
View Study & Checklist ➔Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Impact of HIV-1 and Aging on Mucosal Vaccine Responses
📍 Rocky Mountain Regional VA Medical Center — Aurora, Colorado
View Study & Checklist ➔Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed
📍 UAB 1917 Research Clinic — Birmingham, Alabama
View Study & Checklist ➔Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy
📍 Pueblo Family Physicians — Phoenix, Arizona
View Study & Checklist ➔Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Newborns Exposed to HIV
📍 Ronald Reagan UCLA Medical Center (inpatient hospital) — Los Angeles, California
View Study & Checklist ➔Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
📍 Orlando Immunology Center — Orlando, Florida
View Study & Checklist ➔Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
📍 University of Alabama at Birmingham(UAB) 1917 Research Clinic — Birmingham, Alabama
View Study & Checklist ➔A Study to Evaluate the Safety and Immunogenicity of the V3-region Directed Immunogens DV700P-RNA Followed by DV701B1.1-RNA in Adults Without HIV
📍 University of Alabama Medical Center (Site ID: 31788) — Birmingham, Alabama
View Study & Checklist ➔Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With an Optimized Background Regimen (OBR) in Heavily Treatment Experienced Participants Living With HIV-1 Infection With Multidrug Resistance
📍 Ruane Clinical Research Group Inc — Los Angeles, California
View Study & Checklist ➔Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)
📍 Saskatchewan Health Authority — Regina, Saskatchewan
View Study & Checklist ➔A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection
📍 Alabama CRS — Birmingham, Alabama
View Study & Checklist ➔Observational PIC Destination Cohort
📍 University of California, San Francisco HIV/AIDS CRS (801) — San Francisco, California
View Study & Checklist ➔A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
📍 Helios Salud — Buenos Aires,
View Study & Checklist ➔Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens
📍 Be Well Medical Center — Berkeley, Michigan
View Study & Checklist ➔Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
📍 Syracuse University — Syracuse, New York
View Study & Checklist ➔Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children
📍 Grady Health System, Ponce De Leon Center — Atlanta, Georgia
View Study & Checklist ➔Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
📍 Midway Immunology and Research Center — Ft. Pierce, Florida
View Study & Checklist ➔Ending the Epidemic Interventions in the Dental Setting - UH3
📍 Columbia University Irving Medical Center / NewYork-Presbyterian Hospital — New York, New York
View Study & Checklist ➔Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
📍 University of Southern California (CRS 5048) — Los Angeles, California
View Study & Checklist ➔IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
📍 University of North Carolina — Chapel Hill, North Carolina
View Study & Checklist ➔PrEPsmart 2-1-1 Pilot
📍 Bridge HIV, San Francisco Department of Public Health — San Francisco, California
View Study & Checklist ➔Improving Coronary Vascular Health in Women
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
📍 University of Colorado - Anschutz Medical Campus — Aurora, Colorado
View Study & Checklist ➔A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
📍 Pacific Oak Medical Group — Beverly Hills, California
View Study & Checklist ➔Caspofungin for Pneumocystis Pneumonia in PLWHIV.
📍 Center for Research in Infectious Diseases (CIENI) — Mexico City, Tlalpan
View Study & Checklist ➔Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age
📍 Site 5030, Emory University School of Medicine NICHD CRS — Atlanta, Georgia
View Study & Checklist ➔Cannabis Use, Cognition, and the Endocannabinoid System in HIV
📍 UC San Diego Medical Center-Hillcrest — San Diego, California
View Study & Checklist ➔PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔